Why the study?
The cell-resolved programs linking polyamine homeostasis to post-ischemic myocardial remodeling and the response to spermidine in ischemic heart failure remain unclear.
Population
Bulk and single-nucleus myocardial transcriptomic cohorts and 8-week-old male C57BL/6J mice post-myocardial infarction
Comparison
Spermidine treatment with or without fibroblast-directed FREM1 activation and sham pattern in mice
Design
Integrated multi-omics analysis and experimental post-myocardial-infarction mouse model study
Answers are grounded in this paper and cite their sources.
Spermidine effects in mice do not support clinical use in ischemic HF; leaves open FREM1 as a stratification target for trials.
Ischemic injury drives a sustained myocardial response in which metabolic stress, fibroblast activation, and extracellular-matrix remodeling converge to cause heart failure, yet the cell-resolved programs linking polyamine homeostasis to post-ischemic remodeling and the response to spermidine remain unclear. In this study, we integrated disease-burden estimates with bulk and single-nucleus myocardial transcriptomics, prioritizing polyamine-related genes by differential-expression analysis, gene-set scoring, and machine learning, followed by pathway, immune, cell–cell communication, and regulatory-network analyses, and evaluated spermidine in a post-myocardial-infarction mouse model using 8-week-old male C57BL/6J mice, with fibroblast-directed FREM1 activation to test whether FREM1 modifies the treatment response. Cross-platform analysis identified FREM1, MYH6, ARRDC3, and XAF1 as reproducible components of the ischemic-failing-heart signature, with FREM1 showing the strongest discrimination in the independent cohort; the program localized predominantly to fibroblasts and was linked to extracellular-matrix, inflammatory, and intercellular-signaling states. In mice, spermidine improved systolic function, reduced collagen deposition, shifted MTA and ornithine signals toward the sham pattern, and lowered myocardial FREM1; FREM1 activation weakened these effects, though residual benefit remained. These findings identify a fibroblast-enriched, spermidine-responsive FREM1 remodeling program linking polyamine-associated stress to post-ischemic fibrosis, positioning FREM1 as a candidate regulator of the cardiac response to spermidine and a potential entry point for therapeutic stratification in ischemic heart failure.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: